🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Pennsylvania

Etid klinik pou Kansè (tout kalite) nan Pennsylvania

103 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • IRMC Cancer Center, Indiana
  • UPMC Hillman Cancer Center - New Castle, New Castle
  • ak 2 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

  • Allegheny General Hospital, Pittsburgh
Ap rekriteEtid obsèvasyon
Laj 20 a 89 · Fanm · Mizajou Sep 30, 2026 · NCT07023887

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

  • AHN Allegheny General Hospital, Pittsburgh
  • Allegheny General Hospital, Pittsburgh
Ap rekrite
Laj 20 a 89 · Fanm · Mizajou Sep 30, 2026 · NCT07698314

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

  • AHN Allegheny General Hospital, Pittsburgh
  • AHN Allegheny General Hospital, Pittsburgh
Ap rekrite
Laj 20 a 89 · Fanm · Mizajou Sep 28, 2026 · NCT07704476

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

  • GSK Investigational Site, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07277270

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • Allegheny Health Network, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07195591

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

  • GSK Investigational Site, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07438782

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

  • UPMC Cancer Centers, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06311578

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  • Children's Hospital of Philadelphia (CHOP) ( Site 4021), Philadelphia
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • University of Pennsylvania, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06150157

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • Allegheny General Hospital (AGH)-Allegheny Singer Research Institute, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531

Pan Tumor Rollover Study

  • Lancaster General Health, Lancaster
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03899155

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100), Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07405164

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • St. Lukes University Hospital /ID# 280204, Bethlehem
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Lehigh Valley Hospital - Cedar Crest, Allentown
  • Lehigh Valley Hospital- Muhlenberg, Bethlehem
  • Pocono Medical Center, East Stroudsburg
  • ak 2 plis
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Prospective Study to Assess a Diagnostic Aid for Cancer

  • Susquehanna Research Group, Harrisburg
  • Respiratory Specialists, Wyomissing
  • Cancer Care Associates of York, York
Ap rekriteEtid obsèvasyon
Laj 45 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07046260

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University - Clinical Research Institute, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
  • ak 1 plis
Ap rekriteFaz 2/3
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

  • Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06941272

Collection of Tissue Samples for Cancer Research

  • University of Pittsburgh Medical Center, Pittsburgh
Ap rekriteEtid obsèvasyon
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Pennsylvania, Philadelphia
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • Geisinger Medical Center-Cancer Center Hazleton, Hazleton
  • ak 4 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06756607

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT05123482

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Fox Chase Cancer Center, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Alliance Cancer Specialists, PC, Horsham
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • University of Pennsylvania, Philadelphia
  • Cancer Care Associates of York, York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06163534

Lurbinectedin in FET-Fused Tumors

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 1/2
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

  • Thomas Jefferson University, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06206941

Project: Every Child for Younger Patients With Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • ak 4 plis
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

  • Fox Chase Cancer Center, Philadelphia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07776704

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • Lehigh Valley Health Network, Bethlehem
  • University of Pennsylvania, Philadelphia
  • Allegheny-Singer Research Institution, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05335928

Biennial CEM in Women With a Personal History of Breast Cancer

  • UPMC Magee-Womens Imaging - Bethel Park, Bethel Park
  • UPMC Magee at the Lemieux Sports Complex, Cranberry Township
  • Magee Womancare Monroeville, Monroeville
  • ak 3 plis
Ap rekriteVolontè an sante akeyi
Laj 30 a 79 · Fanm · Mizajou Aug 19, 2026 · NCT06105749

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

  • AHN Allegheny General Hospital, Pittsburgh
Ap rekrite
Laj 20 a 89 · Fanm · Mizajou Aug 17, 2026 · NCT07739563

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Pennsylvania, Perelman School of Medicine, Philadelphia
  • University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

  • University of Pittsburgh Medical Center (UPMC) Cancer Center, Pittsburgh
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07183527

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteFaz 2
Laj 1 a 39 · Tout sèks · Mizajou Aug 7, 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Saint Luke's Cancer Center - Allentown, Allentown
  • Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
  • ak 21 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.